Thomas A. Buchholz

43.6k total citations · 8 hit papers
512 papers, 31.5k citations indexed

About

Thomas A. Buchholz is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas A. Buchholz has authored 512 papers receiving a total of 31.5k indexed citations (citations by other indexed papers that have themselves been cited), including 339 papers in Cancer Research, 220 papers in Oncology and 178 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas A. Buchholz's work include Breast Cancer Treatment Studies (322 papers), Breast Lesions and Carcinomas (168 papers) and Breast Implant and Reconstruction (100 papers). Thomas A. Buchholz is often cited by papers focused on Breast Cancer Treatment Studies (322 papers), Breast Lesions and Carcinomas (168 papers) and Breast Implant and Reconstruction (100 papers). Thomas A. Buchholz collaborates with scholars based in United States, Germany and United Kingdom. Thomas A. Buchholz's co-authors include Gabriel N. Hortobágyi, Kelly K. Hunt, Benjamin D. Smith, Sharon H. Giordano, Henry M. Kuerer, Wendy A. Woodward, Eric A. Strom, Grace L. Smith, Aman U. Buzdar and S. Eva Singletary and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Thomas A. Buchholz

498 papers receiving 30.6k citations

Hit Papers

Future of Cancer Incidence in the United States: Burde... 1999 2026 2008 2017 2009 1999 2005 2009 2010 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
    2009 1.3k citations Benjamin D. Smith, Grace L. Smith et al. Journal of Clinical Oncology profile →
  2. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
    1999 1.1k citations Henry M. Kuerer, Kelly K. Hunt et al. Journal of Clinical Oncology profile →
  3. Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer
    2005 867 citations Aman U. Buzdar, Nuhad K. Ibrahim et al. Journal of Clinical Oncology profile →
  4. Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO)
    2009 621 citations Benjamin D. Smith, Douglas W. Arthur et al. International Journal of Radiation Oncology*Biology*Physics profile →
  5. American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
    2010 612 citations Harold J. Burstein, Holly Anderson et al. Journal of Clinical Oncology profile →
  6. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
    2014 559 citations Harold J. Burstein, Holly Anderson et al. Journal of Clinical Oncology profile →
  7. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
    2017 417 citations W. Fraser Symmans, Kelly K. Hunt et al. Journal of Clinical Oncology profile →
  8. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
    2018 411 citations Harold J. Burstein, Christina Lacchetti et al. Journal of Clinical Oncology profile →

Peers

Thomas A. Buchholz
Umberto Veronesi Italy
Bruce G. Haffty United States
Henry M. Kuerer United States
Richard G. Margolese Canada
Emiel J. Rutgers Netherlands
Harry Bartelink Netherlands
Kelly K. Hunt United States
Stuart J. Schnitt United States
Philip Poortmans Netherlands
Luigi Mariani Italy
Umberto Veronesi Italy
Thomas A. Buchholz
Citations per year, relative to Thomas A. Buchholz Thomas A. Buchholz (= 1×) peers Umberto Veronesi

Countries citing papers authored by Thomas A. Buchholz

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Buchholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Buchholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Buchholz more than expected).

Fields of papers citing papers by Thomas A. Buchholz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Buchholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Buchholz. The network helps show where Thomas A. Buchholz may publish in the future.

Co-authorship network of co-authors of Thomas A. Buchholz

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Buchholz. A scholar is included among the top collaborators of Thomas A. Buchholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Buchholz. Thomas A. Buchholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burstein, Harold J., Christina Lacchetti, Holly Anderson, et al.. (2018). Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. Journal of Clinical Oncology. 37(5). 423–438. 411 indexed citations breakdown →
2.
Sheu, Tommy, et al.. (2017). Lumpectomy With Radiation Versus Mastectomy for Early-Stage Breast Cancer: Value-Based Treatment Considerations. 13(11). 1 indexed citations
3.
Pan, Hubert Y., et al.. (2016). Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025. International Journal of Radiation Oncology*Biology*Physics. 96(2). E394–E395. 3 indexed citations
4.
Smith, Grace L., Jinhai Huo, Sharon H. Giordano, et al.. (2015). Utilization and Outcomes of Breast Brachytherapy in Younger Women. International Journal of Radiation Oncology*Biology*Physics. 93(1). 91–101. 7 indexed citations
5.
Marland, Gregg, et al.. (2013). Accounting for Carbon Dioxide Emissions. Journal of Industrial Ecology. 17(3). 340–342. 15 indexed citations
6.
Guadagnolo, B. Ashleigh, Kai-Ping Liao, Linda S. Elting, et al.. (2012). Use of Radiation Therapy in the Last 30 Days of Life Among a Large Population-Based Cohort of Elderly Patients in the United States. Journal of Clinical Oncology. 31(1). 80–87. 123 indexed citations
7.
Dominici, Laura S., Elizabeth A. Mittendorf, Xumei Wang, et al.. (2012). Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Research. 14(3). R82–R82. 37 indexed citations
8.
Bridges, Kathleen A., Hiroshi Hirai, Carolyn A. Buser, et al.. (2011). MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells. Clinical Cancer Research. 17(17). 5638–5648. 185 indexed citations
9.
Smith, Benjamin D., Jing Jiang, Arti Hurria, et al.. (2011). Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?. Journal of Clinical Oncology. 29(35). 4647–4653. 113 indexed citations
10.
Albert, Jeffrey M., Ana M. González-Angulo, Merih Güray, et al.. (2010). Estrogen/Progesterone Receptor Negativity and HER2 Positivity Predict Locoregional Recurrence in Patients With T1a,bN0 Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1296–1302. 58 indexed citations
11.
Dawood, Shaheenah, Sofía D. Merajver, Patrice Viens, et al.. (2010). International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology. 22(3). 515–523. 331 indexed citations
12.
Dawood, Shaheenah, Yun Yun Gong, Kristine Broglio, et al.. (2010). Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome. The Breast Journal. 16(5). 529–532. 18 indexed citations
13.
Shih, Ya‐Chen Tina, Ying Xu, Janice N. Cormier, et al.. (2009). Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study. Journal of Clinical Oncology. 27(12). 2007–2014. 381 indexed citations
14.
Smith, Benjamin D., Douglas W. Arthur, Thomas A. Buchholz, et al.. (2009). Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO). International Journal of Radiation Oncology*Biology*Physics. 74(4). 987–1001. 621 indexed citations breakdown →
15.
Dawood, Shaheenah, Kristine Broglio, Shu‐Wan Kau, et al.. (2008). Prognostic Value of Initial Clinical Disease Stage After Achieving Pathological Complete Response. The Oncologist. 13(1). 6–15. 19 indexed citations
16.
Rivera, Edgardo, Christina Meyers, Morris D. Groves, et al.. (2006). Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer. 107(6). 1348–1354. 119 indexed citations
17.
Symmans, W. Fraser, Mark Ayers, Edwin Clark, et al.. (2003). Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma. Cancer. 97(12). 2960–2971. 140 indexed citations
18.
Pusztai, Lajos, Mark Ayers, James Stec, et al.. (2003). Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.. PubMed. 9(7). 2406–15. 168 indexed citations
19.
Buchholz, Sven & Thomas A. Buchholz. (2003). Adaptive content networking. 213–219. 1 indexed citations
20.
Starkschall, George, et al.. (2001). Verification of tangential breast treatment dose calculations in a commercial 3D treatment planning system. Journal of Applied Clinical Medical Physics. 2(2). 73–84. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Umberto Veronesi Breakdown of academic impact, for papers by Bruce G. Haffty Breakdown of academic impact, for papers by Henry M. Kuerer Breakdown of academic impact, for papers by Richard G. Margolese Breakdown of academic impact, for papers by Emiel J. Rutgers Breakdown of academic impact, for papers by Harry Bartelink Breakdown of academic impact, for papers by Kelly K. Hunt Breakdown of academic impact, for papers by Stuart J. Schnitt Breakdown of academic impact, for papers by Philip Poortmans Breakdown of academic impact, for papers by Luigi Mariani
Rankless by CCL
2026